[Federal Register Volume 84, Number 226 (Friday, November 22, 2019)]
[Notices]
[Pages 64563-64564]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25402]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-545]


Bulk Manufacturer of Controlled Substances Application: S&B 
Pharma, Inc.

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed on or before January 21, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION:  In accordance with 21 CFR 1301.33(a), this

[[Page 64564]]

is notice that on October 4, 2019, S & B Pharma, Inc., DBA Norac 
Pharma, 405 South Motor Avenue, Azusa, California 91702-3232 applied to 
be registered as a bulk manufacturer of the following basic classes of 
controlled substances:

------------------------------------------------------------------------
          Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid...............            7360               I
Telrahydrocannabinois...................            7370               I
Amphetamine.............................            1100              II
Methamphetamine.........................            1105              II
Lisdexamfetamine........................            1205              II
Methylphenidate.........................            1724              II
Pentobarbital...........................            2270              II
4-Anilino-N-phenethyl-4-piperidine                  8333              II
 (ANPP).................................
Tapentadol..............................            9780              II
Fentanyl................................            9801              II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for use in product development and for commercial sales to its 
customers. In reference to drug code 7360 (marihuana) and 7370 
(tetrahydrocannabinois), the company plans to bulk manufacture both as 
synthetic substances. No other activity for these dug codes is 
authorized for this registration.

    Dated: November 5, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-25402 Filed 11-21-19; 8:45 am]
 BILLING CODE 4410-09-P